Abstract Congenital diaphragmatic hernia (CDH) results from incomplete formation of the diaphragm leading to herniation of abdominal organs into the thoracic cavity. CDH is associated with pulmonary hypoplasia, congenital heart disease, and pulmonary hypertension.
Ontology terms: anteverted nares; aplasia/hypoplasia of the corpus callosum; central hypotonia; congenital diaphragmatic hernia; congenital mitral stenosis; failure to thrive in infancy; frontal hirsutism; malrotation of small bowel; moderate global developmental delay; perimembranous ventricular septal defect; postductal coarctation of the aorta; recurrent respiratory infections (<3rd percentile). She was prenatally diagnosed with left congenital diaphragmatic hernia (CDH), aortic arch hypoplasia, small left-sided cardiac structures, and ventricular septal defect. Genetic amniocentesis documented a normal, 46, XX karyotype and normal chromosomal microarray. The family was counseled as to a poor likelihood for survival based on a heart-lung ratio of 0.86, but elected to carry the twin pregnancy. She required significant respiratory and inotropic support postbirth but was able to undergo CDH repair on day of life (DOL) 5. At 3 mo of age she underwent aortic arch hypoplasia repair with ventricular septal defect closure. Her postoperative course was complicated by arrhythmias and acute hypotension leading to venoarterial (VA)-ECMO cannulation on postoperative day 1 (POD1). She was decannulated on POD4 and underwent delayed sternal closure on POD6. Her hospitalization was further complicated by eight culture-positive respiratory infections with Gram-positive and Gram-negative bacteria between her second week of life and death at 8 mo of age. She received multiple courses of antibiotics for suspected infection. She had feeding intolerance and underwent a Nissen Gastrostomy tube placement at 4 mo of age. Genetics consultation at 5 mo of age documented a delayed, dysmorphic, and hirsute infant with unusual penciled eyebrows, a medial eyebrow flare, anteverted nares, and posteriorly rotated ears, but well developed nails with no distal phalangeal hypoplasia (Table 1) . A specific pattern of malformation was not recognized. A postnatal microarray was normal. Exome sequencing was suggested, but the funding was not approved. At 6 mo of age she underwent exploratory laparotomy for lysis of adhesions in the setting of a small bowel obstruction. There was no bowel loss. She was reintubated at 7 mo of age for respiratory failure. At that time she also developed atrial flutter requiring medical cardioversion with sotalol. She failed a trial of extubation and underwent a tracheostomy for procurement of a more stable airway. Sotalol was discontinued after 9 d of treatment in the setting of high-grade atrioventricular block. She had chronic lung disease (CLD), iatrogenic neonatal abstinence syndrome (NAS), persistent electrolyte derangements, and refractory metabolic alkalosis on diuretic therapy. The option for palliative care was presented on multiple occasions during the patient's hospitalization. Parental consensus on a decision could never be reached as one of the parents held out hope that advancements in technology would address most of the patient's health concerns in the absence of a confirmed diagnosis. Soon after referral for rapid wholegenome sequencing (rWGS), she developed another episode of respiratory failure requiring oscillatory ventilation. At the time of rWGS diagnosis she was found to be in septic shock requiring inotropic support with multiple agents. After meeting with genetic specialists to discuss the diagnosis and prognosis, the family opted for withdrawal of life support given the patient's critical condition and the fact that the underlying genetic condition could not be cured.
The patient had an unaffected 7-yr-old brother and an unaffected twin brother. Her parents were both healthy. Her mother, age 37, identified as Hispanic and her father, age 42, as Caucasian Italian. Her mother had a history of a miscarriage at 3 mo gestation prior to this twin pregnancy. There was a maternal female cousin born with tricuspid atresia, who had required at least four surgeries.
TECHNICAL ANALYSIS AND METHODS
The patient had a normal newborn screen, normal female karyotype (prenatal testing), and a normal female chromosomal microarray both prenatally (ARUP) and postnatally (Quest Diagnostics). rWGS became available during her seventh month of life.
One day after consent for trio rWGS, DNA was extracted and sequenced using an Illumina HiSeq X (Hudson Alpha) with paired 151-nt reads. The average library insert size was 369 nt for proband. Sequencing was completed 7 d after consent. Rapid alignment Late diagnosis of Coffin-Siris syndrome by rWGS and nucleotide-variant calling was performed using the Dragen (Edico Genome) hardware and software (Miller et al. 2005 Table S1 ). Variants were automatically annotated and analyzed in Opal Clinical (Omicia) (Coonrod et al. 2013) . Initially, variants were filtered to retain those with allele frequencies of <1% in the Exome Variant Server, 1000 Genomes Samples, and Exome Aggregation Consortium database (http://evs.gs.washington.edu/ EVS/2016; Karczewski et al. 2016) . A differential diagnostic gene list was built in Phenolyzer (Yang et al. 2015) Late diagnosis of Coffin-Siris syndrome by rWGS (Richards et al. 2015) . Two variants were classified as variants of uncertain significance: c.422A>C (p.Glu141Ala) in NDUFAF4, and c.685_686insCGC (p.Gln228_Gln229insPro) in SMARCA2. The ARID1B p.Lys1033Argfs * 32 was classified as likely pathogenic (Supplemental Table S2 ) and was confirmed by Sanger Sequencing.
VARIANT INTERPRETATION
Interpretation of the rWGS results for this patient determined a de novo alteration in the ATrich DNA interacting domain-containing protein 1B (ARID1B) gene, c.3096_3100delCAAAG (p.Lys1033ArgfsTer32), following genetic analysis of proband and both parents (Table 2) . ARID1B is a component of a chromatin remodeling complex involved in cell cycle activation and is one of the genes that cause Coffin-Siris syndrome (CSS). CSS is a multisystem disease associated with congenital anomalies (congenital diaphragmatic hernia, spinal anomalies, and congenital heart defects), dysmorphic features, recurrent infections, and developmental delay. The prevalence of CSS has been estimated at <1:100,000. Multiple genes have been implicated in this syndrome including ARID1A, ARID1B, SMARCA2, SMARCA4, SMARCB1, and SMARCE1 (Tsurusaki et al. 2012) . Inheritance is autosomal dominant. The major features of CSS are intellectual disability, speech delay, coarse facies, and hypertrichosis. Prevalent features are hypoplasia of the fifth digits/nails of hand/feet, feeding difficulties, and agenesis of the corpus callosum. Other more variable features include poor overall growth, craniofacial abnormalities, congenital diaphragmatic hernia, spinal anomalies, and congenital heart defects (Santen et al. 2014 ). The classic phenotype of CSS with hypoplastic distal phalanges and nails of the fifth fingers, the most distinct and objective of the classic features of CSS, is not always seen. As with many other conditions, the identification of the molecular basis of a specific condition has led to the expansion of the clinical phenotype, and features such as hypertrichosis, hypoplastic nails, or obvious coarse facial features have been found to be more subtle or absent in many cases. Others, such as hyperkeratosis, have only been recently recognized (Zweier et al. 2017 ). More importantly, ARID1B is now recognized as one of the most frequent genes causing nonsyndromic intellectual disability (Santen et al. 2014) .
The c.3096_3100delCAAAG (p.Lys1033ArgfsTer32) in ARID1B is a novel frameshift alteration leading to a premature termination codon. This deletion was not found in the 1000 Genomes, Exome Variant Server (EVS), or ExAC databases. Thus, it is presumed to be rare. Although this particular variant has not been reported in the literature, pathogenic alterations similar to this one have been reported (Hoyer et al. 2012) . Based on the combined evidence, this variant is classified as likely pathogenic for CSS. 
Late diagnosis of Coffin-Siris syndrome by rWGS C O L D S P R I N G H A R B O R
The incidence of CDH is 1 in 2000-5000 births (Chen et al. 2007a) , and it comprises 8% of all birth defects (Yu et al. 2015) . It is the cause of 1%-2% of infant mortalities. CDH is caused by the incomplete formation of the diaphragm around the fourth to eighth week of gestation. Greater than 95% form posterior lateral (Bochdaleck) and ∼2% are anterior retrosternal or parasternal. Eighty-five percent of CDHs are on the left side of the body. Forty percent of CDH cases are associated with at least one additional anomaly like pulmonary hypoplasia, congenital heart disease, pulmonary hypertension, or other genetic anomalies (Yu et al. 2015) .
More than 50 different genetic syndromes have been associated with CDH, ranging from aneuploidies (trisomy 18 is seen in 1%-2% of CDH), copy-number variations (tetrasomy 12p, 8p23.1 deletion, 15q26.1 deletion, 1q41-42 deletion, 8q23.1 deletion, 4p16 deletion, 11q23.2 deletion) (Wynn et al. 2014; Stark et al. 2015) , autosomal dominant disorders (WT1-opathies, Cornelia de Lange syndrome, Marfan syndrome, Kabuki syndrome), autosomal recessive disorders (Fryns syndrome), and X-linked disorders (craniofrontonasal syndrome, Simpson-Golabi-Behmel, focal dermal hypoplasia). Nonsyndromic single gene mutations (GATA4, ZFPM2/FOG2, DIPS1) have also been reported. The causes of 80% of CDH cases are still unknown and are thought to be multifactorial (Wynn et al. 2014) , although some genetic cases may not be detected by current testing strategies.
CDH is associated with a high rate of functional impairment. In a cross-sectional study of CDH repair survivors at Boston Children's Hospital, it was found that 66% had major medical issues at discharge, whereas 48% still had a current clinical problem on follow-up around 8 yr of age (Chen et al. 2007a) . Neonatal predictors of ongoing medical morbidity were prior ECMO use, presence of cardiac disease, and associated genetic abnormalities. Medical problems reported were related to vision, hearing, muscle weakness, speech, behavior, learning, eating, and breathing (Chen et al. 2007b) .
CDH is the most expensive noncardiac congenital anomaly. Based on the analysis of data obtained from approximately 200 hospitals in the United States (KID database; https://www. hcup-us.ahrq.gov/kidoverview.jsp) from 1997 to 2006, it is estimated that the national cost for management of surviving CDH patients is ∼$158 million/yr. The national cost for management of all CDH patients (including the ones who do not survive to discharge) is >$250 million/yr. ECMO support is associated with a 2.4-3.5-fold increase in expenditure (Raval et al. 2011) . Figure 1 shows the cumulative hospital costs at the time of the patient's death, which were >$1.8 million. The cost of rWGS at the time was $8482 for a singleton and $17,579 for a trio. The average cost of commercial WES including analysis is estimated at $4000. At our institution WES is usually performed outpatient with a turnaround time of 6-8 wk because this test is not covered while inpatient. Hospital cost for taking care of this child if she were referred to us on DOL0, assuming a rWGS diagnosis on DOL14 (the results for this patient were available by day 7 of enrollment) and time of death of 6 d following approach of the family for withdrawal of life support (W/LS), would have been a little more than $115,000. Literature review shows that the time from approach of families for W/LS to the child's death can range anywhere from 2-6 d depending on whether the patient is in the United States or Europe (Keenan et al. 1997; Garros et al. 2003; Devictor et al. 2008) . The cost if referred on DOL4 would have been a little more than $130,000. If we are willing to spend more than $1.8 million attempting to improve the quality of life of these critically ill children, this case demonstrates that the cost of genomic sequencing should not be prohibitive to its implementation in their care.
SUMMARY
CDH is the most expensive noncardiac congenital anomaly and is associated with significant long-term functional impairment. Genetic testing should be pursued early in the 
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